Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Colorcon
Medtronic
Boehringer Ingelheim

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018977

See Plans and Pricing

« Back to Dashboard

NDA 018977 describes TRI-NORINYL 28-DAY, which is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. Additional details are available on the TRI-NORINYL 28-DAY profile page.

The generic ingredient in TRI-NORINYL 28-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 018977
Tradename:TRI-NORINYL 28-DAY
Applicant:Mayne Pharma
Ingredient:ethinyl estradiol; norethindrone
Patents:0
Suppliers and Packaging for NDA: 018977
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRI-NORINYL 21-DAY ethinyl estradiol; norethindrone TABLET;ORAL-21 018977 NDA AUTHORIZED GENERIC Mayne Pharma Inc. 51862-471 51862-471-06 6 BLISTER PACK in 1 CARTON (51862-471-06) > 1 KIT in 1 BLISTER PACK (51862-471-01)
TRI-NORINYL 28-DAY ethinyl estradiol; norethindrone TABLET;ORAL-28 018977 NDA AUTHORIZED GENERIC Mayne Pharma Inc. 51862-471 51862-471-06 6 BLISTER PACK in 1 CARTON (51862-471-06) > 1 KIT in 1 BLISTER PACK (51862-471-01)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
Approval Date:Apr 13, 1984TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
Approval Date:Apr 13, 1984TE:ABRLD:Yes

Expired US Patents for NDA 018977

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mayne Pharma TRI-NORINYL 21-DAY ethinyl estradiol; norethindrone TABLET;ORAL-21 018977-001 Apr 13, 1984   Start Trial   Start Trial
Mayne Pharma TRI-NORINYL 28-DAY ethinyl estradiol; norethindrone TABLET;ORAL-28 018977-002 Apr 13, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
Colorcon
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.